At the ESPHM Congress 2026, we are presenting new insights from a large retrospective analysis on false positive rates in commercial ELISA tests for PRRSv and Mycoplasma hyopneumoniae in European pig breeding farms.

Using data from more than 60 sites across Europe, the study highlights how gender, laboratory and time can influence test outcomes – with important implications for diagnostics and herd health decision‑making.

Visit us at ESPHM 2026 and discover the full results.